At Innovenn, we are committed to fulfilling the unmet needs of patients and providing tools and insights to doctors and patients to help with disease management. Using AI technology, we can provide a custom patient disease profile and progression analysis which informs current and future care.
Innovenn has spend years developing a unique technology to understand how to optimize the use of clinical and scientific data and then create predictive modeling at an individual patient level. Our approach is to collaborate closely with our client partners through every aspect of the development of a new SaMD solution based on our clients’ needs including; identification of unmet needs, delineate business requirements, UX, SaMD development, validation, testing, training and launch.
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable medical solutions. With our Rx+TM strategy, we aim to create innovative healthcare solutions that combine our strengths in the prescription drug (Rx) business developed over many years with technologies and knowledge from fields outside of the traditional Rx space. Digital Therapeutics is one of example of the focus of our Rx+TM strategy.